Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract 1187: The role of PI3K as a biomarker

Michael Amatulli, Laura A. Brennan, Dhanvanthri S. Deevi, Marie Prewett, James R. Tonra, Keren Paz

Cancer Res (2010) 70 (8_Supplement): 1187.

https://doi.org/10.1158/1538-7445.AM10-1187

Published: 15 April 2010

View article titled, Abstract 1187: The role of PI3K as a biomarker

Journal Articles

Abstract #4089: Mechanism of potentiation of the antitumor cytotoxic therapy by treatment with an antagonist antibody to VEGFR-3 in subcutaneous tumor xenograft models

Marguerita OMahony, Hui Xiao, Marie Prewett, Rajiv Bassi, Chris Damoci, James Tonra, Bronislaw Pytowski

Cancer Res (2009) 69 (9_Supplement): 4089.

Published: 01 May 2009

View article titled, Abstract #4089: Mechanism of potentiation of the antitumor cytotoxic therapy by treatment with an antagonist antibody to VEGFR-3 in subcutaneous tumor xenograft models

Journal Articles

Abstract #701: The role of KRAS as a biomarker

Michael Amatulli, Jaimie Slade, Jennifer O'Toole, Dhanvanthri Deevi, Marie Prewett, James Tonra, Laura Brennan, Keren Paz

Cancer Res (2009) 69 (9_Supplement): 701.

Published: 01 May 2009

View article titled, Abstract #701: The role of KRAS as a biomarker

Journal Articles

Abstract #694: The role of BRAF as a biomarker

Michael Amatulli, Laura Brennan, Jaimie Slade, Jennifer O'Toole, Dhanvanthri Deevi, Marie Prewett, James Tonra, Keren Paz

Cancer Res (2009) 69 (9_Supplement): 694.

Published: 01 May 2009

View article titled, Abstract #694: The role of BRAF as a biomarker

Journal Articles

Abstract #2774: The fully human EGFR antibody IMC-11F8 significantly increases the antitumor effects of cisplatin+gemcitabine in human non-small cell lung cancer models

Marie Prewett, Rajiv Bassi, Hagop Youssoufian, Eric Rowinsky, James Tonra

Cancer Res (2009) 69 (9_Supplement): 2774.

Published: 01 May 2009

View article titled, Abstract #2774: The fully human EGFR antibody IMC-11F8 significantly increases the antitumor effects of cisplatin+gemcitabine in human non-small cell lung cancer models

Journal Articles

Cetuximab significantly increases the anti-tumor effects of irinotecan + oxaliplatin (IROX) in human colorectal cancer xenograft models.

Marie Prewett, Rajiv Bassi, James Tonra

Cancer Res (2008) 68 (9_Supplement): 1322.

Published: 01 May 2008

View article titled, Cetuximab significantly increases the anti-tumor effects of irinotecan + oxaliplatin (IROX) in human colorectal cancer xenograft models.

Journal Articles

Neutralizing antibody against FGFR3 shows anti-tumor effects in multiple tumor models in vivo

Roberto DiRenzo, Maria Malabunga, Marie Prewett, Rajiv Bassi, David Surguladze, Juqun Shen, James Tonra, Paul Kussie, Haijun Sun

Cancer Res (2007) 67 (9_Supplement): 2080.

Published: 01 May 2007

View article titled, Neutralizing antibody against FGFR3 shows anti-tumor effects in multiple tumor models in vivo

Journal Articles

Mechanism for the benefits of cetuximab in combination with oxaliplatin, in oxaliplatin sensitive and resistant colon cancer cell lines

Dhanvanthri Deevi, Rajiv Bassi, Maxine Melchior, Lee Ellis, Fan Fan, Daniel Hicklin, James Tonra, Marie Prewett

Cancer Res (2007) 67 (9_Supplement): 2329.

Published: 01 May 2007

View article titled, Mechanism for the benefits of cetuximab in combination with oxaliplatin, in oxaliplatin sensitive and resistant colon cancer cell lines

Journal Articles

IMC-A12 enhances the efficacy of cetuximab + gemcitabine therapy in human pancreatic carcinoma xenografts.

Marie Prewett, Christopher Damoci, Rajiv Bassi, Dale Ludwig, Daniel Hicklin, James Tonra

Cancer Res (2007) 67 (9_Supplement): 652.

Published: 01 May 2007

View article titled, IMC-A12 enhances the efficacy of cetuximab + gemcitabine therapy in human pancreatic carcinoma xenografts.

Journal Articles

An Antibody directed against platelet-derived growth factor β receptor suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody

juqun shen, Marie Vil, Haifan Zhang, James Tonra, Nick Loizos, Paul Balderes, Marie Prewett, Chris Damoci, Anthony Kayas, Xenia Jimenez, Michelle Iacolina, Heather Griffith, Dale Ludwig, Zhenping Zhu

Cancer Res (2007) 67 (9_Supplement): 4790.

Published: 01 May 2007

View article titled, An Antibody directed against platelet-derived growth factor β receptor suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody

Journal Articles

Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member

Jennifer M. O'Toole, Karen E. Rabenau, Kerri Burns, Dan Lu, Venkat Mangalampalli, Paul Balderes, Nicole Covino, Rajiv Bassi, Marie Prewett, Kimberly J. Gottfredsen, Megan N. Thobe, Yuan Cheng, Yiwen Li, Daniel J. Hicklin, Zhenping Zhu, Susan E. Waltz, Michael J. Hayman, Dale L. Ludwig, Daniel S. Pereira

Cancer Res (2006) 66 (18): 9162–9170.

https://doi.org/10.1158/0008-5472.CAN-06-0283

Published: 18 September 2006

View article titled, Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member

Includes: Supplementary data

Journal Articles

Antibody mediated VEGFR-3 inhibition potentiates the anti-tumor effects of cytotoxic therapy in subcutaneous xenograft models

James R. Tonra, Marie Prewett, Rajiv Bassi, Chris Damoci, Kris Persaud, Daniel J. Hicklin, Bronislaw Pytowski

Cancer Res (2006) 66 (8_Supplement): 875–876.

Published: 15 April 2006

View article titled, Antibody mediated VEGFR-3 inhibition potentiates the anti-tumor effects of cytotoxic therapy in subcutaneous xenograft models

Journal Articles

Enhanced anti-tumor activity with cetuximab (ERBITUX®) in combination with oxaliplatin in human colon carcinoma xenografts

Marie Prewett, James R. Tonra, Rajiv Bassi, Francine Carrick, Genevieve Makhoul, Bridget Finnerty, Larry Witte, Peter Bohlen, Daniel J. Hicklin

Cancer Res (2005) 65 (9_Supplement): 1192.

Published: 01 May 2005

View article titled, Enhanced anti-tumor activity with cetuximab (ERBITUX®) in combination with oxaliplatin in human colon carcinoma xenografts

Journal Articles

Potent anti-tumor activity of IGF-I receptor antagonist antibody IMC-A12 alone and in combination with CPT-11.

Dale L. Ludwig, James R. Tonra, Douglas Burtrum, Marie Prewett, Rajiv Bassi, Andrea Hooper, Daniel S. Pereira, Bridget Finnerty, Eric Corcoran, Larry Witte, Daniel J. Hicklin

Cancer Res (2004) 64 (7_Supplement): 509.

Published: 01 April 2004

View article titled, Potent anti-tumor activity of IGF-I receptor antagonist antibody IMC-A12 alone and in combination with CPT-11.

Journal Articles

Antitumor activity of a novel, human anti-epidermal growth factor receptor (EGFR) monoclonal antibody (IMC-11F8) in human tumor xenograft models

Marie Prewett, James R. Tonra, Bassi Rajiv, Andrea T. Hooper, Genevieve Makhoul, Bridget Finnerty, Larry Witte, Peter Bohlen, Zhenping Zhu, Daniel J. Hicklin

Cancer Res (2004) 64 (7_Supplement): 1235.

Published: 01 April 2004

View article titled, Antitumor activity of a novel, human anti-epidermal growth factor receptor (EGFR) monoclonal antibody (IMC-11F8) in human tumor xenograft models

Journal Articles

A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo

Douglas Burtrum, Zhenping Zhu, Dan Lu, Donna Marie Anderson, Marie Prewett, Daniel S. Pereira, Rajiv Bassi, Rashed Abdullah, Andrea T. Hooper, Henry Koo, Xenia Jimenez, Danielle Johnson, Robin Apblett, Paul Kussie, Peter Bohlen, Larry Witte, Daniel J. Hicklin, Dale L. Ludwig

Cancer Res (2003) 63 (24): 8912–8921.

Published: 24 December 2003

View article titled, A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo

Journal Articles

Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors

Marie Prewett, James Huber, Yiwen Li, Angel Santiago, William O’Connor, Karen King, Jay Overholser, Andrea Hooper, Bronislaw Pytowski, Larry Witte, Peter Bohlen, Daniel J. Hicklin

Cancer Res (1999) 59 (20): 5209–5218.

Published: 01 October 1999

View article titled, Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors

Journal Articles

Immunotherapy of Human Glioma Xenografts with Unlabeled, ¹³¹I-, or ¹²⁵I-labeled Monoclonal Antibody 425 to Epidermal Growth Factor Receptor

Hans Bender, Hiroshi Takahashi, Koji Adachi, Paul Belser, Shaohong Liang, Marie Prewett, Martin Schrappe, Arne Sutter, Ulrich Rodeck, Dorothee Herlyn

Cancer Res (1992) 52 (1): 121–126.

Published: 01 January 1992

View article titled, Immunotherapy of Human Glioma Xenografts with Unlabeled, 131I-, or 125I-labeled Monoclonal Antibody 425 to Epidermal Growth Factor Receptor

NARROW

Abstract 1187: The role of PI3K as a biomarker

Abstract #4089: Mechanism of potentiation of the antitumor cytotoxic therapy by treatment with an antagonist antibody to VEGFR-3 in subcutaneous tumor xenograft models

Abstract #701: The role of KRAS as a biomarker

Abstract #694: The role of BRAF as a biomarker

Abstract #2774: The fully human EGFR antibody IMC-11F8 significantly increases the antitumor effects of cisplatin+gemcitabine in human non-small cell lung cancer models

Cetuximab significantly increases the anti-tumor effects of irinotecan + oxaliplatin (IROX) in human colorectal cancer xenograft models.

Neutralizing antibody against FGFR3 shows anti-tumor effects in multiple tumor models in vivo

Mechanism for the benefits of cetuximab in combination with oxaliplatin, in oxaliplatin sensitive and resistant colon cancer cell lines

IMC-A12 enhances the efficacy of cetuximab + gemcitabine therapy in human pancreatic carcinoma xenografts.

An Antibody directed against platelet-derived growth factor β receptor suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody

Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member

Antibody mediated VEGFR-3 inhibition potentiates the anti-tumor effects of cytotoxic therapy in subcutaneous xenograft models

Enhanced anti-tumor activity with cetuximab (ERBITUX®) in combination with oxaliplatin in human colon carcinoma xenografts

Potent anti-tumor activity of IGF-I receptor antagonist antibody IMC-A12 alone and in combination with CPT-11.

Antitumor activity of a novel, human anti-epidermal growth factor receptor (EGFR) monoclonal antibody (IMC-11F8) in human tumor xenograft models

A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo

Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors

Immunotherapy of Human Glioma Xenografts with Unlabeled, ¹³¹I-, or ¹²⁵I-labeled Monoclonal Antibody 425 to Epidermal Growth Factor Receptor

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only